Carregant...
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study
The addition of sildenafil to nintedanib treatment does not improve outcomes to a greater extent than monotherapy with nintedanib, and it is not recommended for IPF subjects http://ow.ly/Gaq530o9kEg
Guardat en:
| Publicat a: | Breathe (Sheff) |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
European Respiratory Society
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6544796/ https://ncbi.nlm.nih.gov/pubmed/31191729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/20734735.0016-2019 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|